House

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor,Engineered for Demanding Fleet Applications

01-15

Thunes and Hyperwallet, a PayPal Service, Expand Payout Access for Merchants Across Asia-Pacific

SAN FRANCISCO,Jan. 14,2025-- Thunes,the Smart Superhighway to move money around the world,today welcomesHyperwallet,a PayPal service for global payouts,as a Member of Thunes\' Direct Global Network. A

01-15

RSM ramps up Asia Hub capabilities with new RSM Hong Kong Advisory firm

SINGAPORE,Jan. 14,2025-- RSM Hong Kong Advisory is pleased to announce the official opening of its office on 15 January 2025.

01-15

Frost & Sullivan Recognizes RapidSOS with the 2024 Product Leadership Award for Enhancing Public Safety Through Next-Gen Emergency Response Technology

RapidSOS\'s transformative platforms leverage artificial intelligence (AI) and connected data from over 540 million connected devices,sensors and apps to streamline emergency communications and impro

01-15

Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq

ONTARIO,Calif.,Jan. 15,2025-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,today

01-15

Vanpowers Unveiled Advanced Smart System at CES 2025: Redefining the Future of Intelligent Cycling

LAS VEGAS,Jan. 15,2025-- Vanpowers,a global leader in e-bike innovation,made waves at CES 2025 with its Advanced Smart System,a groundbreaking integration of adaptive technology set to redefine cyclin

01-15

AM Green and DP World Join Forces to Establish India as a Global Hub for Green Molecules

Aiming to export 2 MTPA of green fuels,this partnership positions India as a leader in global decarbonization efforts.

01-15 AM Green

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

01-15 ImmunoForge

Verkada Expands Leadership Team to Drive JAPAC Channel Growth

Boudewijn Pesch Joins Verkada as Vice President of JAPAC Channel Sales SAN MATEO,Calif.,Jan. 15,2025-- Verkada,a leader in cloud-based physical security,today announced the appointment of Boudewijn P

01-15 Verkada

Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering

NEW YORK,Jan. 15,2025-- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"),a leading provider of OTC pharmaceutical cross-border e-commerce

01-15 Hong Kong Pharma Digital Technology Holdings Limited
Home Previous 1 2 3 4 5 6 Next Tail

10 Items Per Page (Page 3 / 53) Total 527 Items

©copyright2009-2020Beauty Information Network      Contact Us   SiteMap